SBI Healthcare Opportunities Fund Direct Growth
Equity
Direct
Sector - Healthcare
NAV as on 04-10-2024
₹ 473.11
1D
Inception Returns
19.2%
/yr
About the Fund
SBI Healthcare Opportunities Fund Direct Growth is an equity fund. This fund was started on 1 January, 2013. The fund is managed by Tanmaya Desai, Mohit Jain. The fund could potentially beat inflation in the long-run.
Key Parameters
- SBI Healthcare Opportunities Fund Direct Growth has ₹3203 Cr worth of assets under management (AUM) as on Aug 2024 and is more than category average.
- The fund has an expense ratio 0.9.
Returns
SBI Healthcare Opportunities Fund Direct Growth has given a CAGR return of 19.17% since inception. Over the last 1, 3 and 5 years the fund has given a CAGR return of 51.64%, 21.85% and 32.72% respectively.
Holdings
SBI Healthcare Opportunities Fund Direct Growth has allocated its funds majorly in Cash Equivalent, Health, Basic Materials. Its top holdings are Sun Pharmaceuticals Industries Ltd, Divi's Laboratories Ltd, Lupin Ltd, Max Healthcare Institute Ltd Ordinary Shares, Cipla Ltd
Taxation
As it is a sector - healthcare mutual fund the taxation is as follows:For short term (less than a year) capital gains will be taxed at 15%For long term (more than 1 year) capital gains will be taxed at 10% without indexation benefitDividends will always be taxed at slab rate. Gains upto Rs 1 lakh are exempt in case of long term.
Investment objective of SBI Healthcare Opportunities Fund Direct Growth
To provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Minimum Investment and lockin period
Minimum investment for lump sum payment is INR 5000.00 and for SIP is INR 500.00. SBI Healthcare Opportunities Fund Direct Growth has no lock in period.
Historical NAV & Returns
Annualised
▲
▼
2635 people have invested ₹ 2Cr in SBI Healthcare Opportunities Fund Direct Growth in the last three months
INDmoney Rank
Powered by IND quant engine
IND ranking is not available for this fund.
3Y returns in the top 25% of the category
Beats FD returns for both 3Y & 5Y duration
No bad points found for this fund.
Fund Overview
| Expense ratio | 0.9% |
Benchmark | S&P BSE Healthcare PR |
| AUM | ₹3203 Cr |
| Inception Date | 1 January, 2013 |
| Min Lumpsum/SIP | ₹5000/₹500 |
Exit Load | 0.5% |
| Lock In | No Lock-in |
TurnOver | 43.14% |
| STCG | Redeeming before 1 year, returns taxed at 20%. |
| LTCG | After 1 year, 12.5% tax on returns over ₹1.25 lakh/year. |
| Risk |   Very High Risk |
Trailing Returns
as on (04-Oct-24)
Fund Distribution
as on (31-Aug-24)
Small cap
33.1%
Large cap
29.6%
Mid cap
25.7%
Sector Allocation
Health
93.6%
Basic Materials
6.4%
All changes are between Jun'24 and Aug'24
- This fund’s returns stands at 6.73% whereas the fund’s underlying benchmark Nifty 500 returns stands at 0.97% as on Aug'24
- This fund outperformed Nifty 500 by 5.76% in Aug'24
- AUM of the fund stands at 3.2K Cr as of Aug'24
- AUM increased by 223.1 Cr between Aug'24 and Jul'24
Top Stocks bought last month
Lupin Ltd's allocation increased from 4.28% to 5.6%
Suven Pharmaceuticals Ltd's allocation increased from 1.15% to 2.01%
Krishna Institute of Medical Sciences Ltd's allocation increased from 3.6% to 3.95%
Top Stocks sold last month
Sun Pharmaceuticals Industries Ltd's allocation decreased from 12.7 % to 11.94 %
Divi's Laboratories Ltd's allocation decreased from 6.61 % to 5.73 %
Max Healthcare Institute Ltd Ordinary Shares's allocation decreased from 6.5 % to 5.44 %
Mid Cap allocation has gone down from 28.8% to 25.7%
Large Cap allocation has gone down from 34% to 29.6%
Small Cap allocation has gone up from 30.6% to 33.1%
Cash allocation has gone up from 2.6% to 3.8%
Top 2 Sectors in August were Health, Basic Materials
Aug'24
Health
94%
Basic Materials
6%
Jul'24
Health
93%
Basic Materials
7%
See all
Top Growth Drivers | 1M Return |
|---|---|
 Ami Organics Ltd | 15.9% |
 Max Healthcare Institute Ltd | 4.6% |
 Sun Pharmaceuticals Industries Ltd | 4.6% |
Loading...
We are taking more time than usual
Tanmaya Desai
Fund Manager of SBI Healthcare Opportunities Fund Direct Growth, since 1 June 2011
Top funds managed
Mohit Jain
Fund Manager of SBI Healthcare Opportunities Fund Direct Growth, since 30 November 2017
Top funds managed
Fund House
SBI Funds Management Ltd
Total Schemes
Total AUM
₹7.47L Cr
as on 31-Aug-2024
Address
9th Floor, Crescenzo,,C-38 & 39, G Block, Bandra Kurla Complex,,Bandra (East), Mumbai
Phone
91-22-66142900
Website
partnerforlife@sbimf.com
Mutual Fund Insights
In the last 1 year, Quant Healthcare Fund Direct Growth has given 63.48% return, outperforming this fund by 11.83%.
In the last 5 years, DSP Healthcare Fund Direct Growth has given 35% return, outperforming this fund by 2.27% per annum.
Over the last 6 months, this fund has decreased expense ratio by 10.0% moving from 1.00 to 0.90.
This fund has one of the lowest expense ratio in the category (sector - healthcare). Its expense ratio is 0.9% which is lower than the category average expense ratio of 1.39%.
In the last 3 years, ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth has given 22.43% return, outperforming this fund by 0.58% per annum.
SBI Healthcare Opportunities Fund Direct Growth Highlights
Very High Risk
Investors understand that their principal will be at Very High Risk
About the fund
This fund has delivered an average annual returns of 19.17% since inception which is less than its category average return of 27.79%
Fund Allocations
This fund has an allocation of 96.24% in Equity, 0% in Debt and 3.76% in Cash related instruments
AUM size ₹0 Cr
This fund has AUM of ₹0 Cr which is more than its category average of ₹ 2063 Cr
Expense Ratio 0.9%
This fund has an expense ratio of 0.9% which is less than its category average expense ratio of 1.42%
Frequently Asked Questions
The current NAV of SBI Healthcare Opportunities Fund Direct Growth is ₹473.11 as on 04-Oct-2024.
Existing (Absolute + CAGR) as on 04-Oct-2024.
SBI Healthcare Opportunities Fund Direct Growth | Absolute Returns | CAGR Returns |
1 Month Returns | 1.24% | 1.24% |
6 Month Returns | 20.57% | 20.57% |
1 Year Returns | 51.64% | 51.64% |
3 Years Returns | 80.92% | 21.85% |
5 Years Returns | 311.87% | 32.72% |
With INDmoney, the process of investing is very simple and involves zero commission.
- Click Buy on the fund name.
- Input the amount you are looking to invest.
- Select Lump Sum or SIP (Weekly, Monthly or Quarterly).
- Select your bank account and proceed with Payment.
0.9% as on September 2024
₹3203 Cr as on September 2024
Sun Pharmaceuticals Industries Ltd(11.94%), Divi's Laboratories Ltd(5.73%), Lupin Ltd(5.6%), Max Healthcare Institute Ltd Ordinary Shares(5.44%), Cipla Ltd(5.17%) as on September 2024
The alpha ratio for the SBI Healthcare Opportunities Fund Direct Growth for various period is as follows:
Fund Name | Alpha 1 Year | Alpha 3 Years | Alpha 5 Years |
SBI Healthcare Opportunities Fund Direct Growth | 2.23 | 3.76 | 4.88 |
As on September 2024
The alpha for SBI Healthcare Opportunities Fund Direct Growth is calculated against S&P BSE Healthcare PR. Higher alpha indicates that this fund has generated extra returns compared to the benchmark index. An alpha of 1.0 means the fund has outperformed its benchmark index by 1%.
The Beta ratio for the SBI Healthcare Opportunities Fund Direct Growth for various period is as follows:
Fund Name | Beta 1 Year | Beta 3 Years | Beta 5 Years |
SBI Healthcare Opportunities Fund Direct Growth | 0.85 | 0.89 | 0.87 |
As on September 2024
The Beta for SBI Healthcare Opportunities Fund Direct Growth is calculated with S&P BSE Healthcare PR. Beta tells the volatility of the mutual fund relative to its benchmark. If the beta of a mutual fund is more than 1, then the mutual fund is more volatile than its benchmark. If beta is less than 1, then the mutual fund is less volatile than the benchmark.
The sharpe ratio for the SBI Healthcare Opportunities Fund Direct Growth for various period is as follows:
Fund Name | Sharpe Ratio 1 Year | Sharpe Ratio 3 Years | Sharpe Ratio 5 Years |
SBI Healthcare Opportunities Fund Direct Growth | 2.58 | 1.09 | 1.42 |
As on September 2024
The sharpe ratio for SBI Healthcare Opportunities Fund Direct Growth is calculated with S&P BSE Healthcare PR. Sharpe ratio tells risk-adjusted-returns of the mutual fund. The higher a fund's Sharpe ratio, the better a fund's returns have been relative to the risk it has taken on.
The standard deviation for the SBI Healthcare Opportunities Fund Direct Growth for various period is as follows:
Fund Name | Standard Deviation 1 Year | Standard Deviation 3 Years | Standard Deviation 5 Years |
SBI Healthcare Opportunities Fund Direct Growth | 13.95 | 14.82 | 17.54 |
As on September 2024
Standard deviation tells the volatility of the returns of the mutual fund. The higher a fund's Standard deviation, the higher the volatility of the fund's returns.
Sortino ratio is 1.9 as on September 2024. Sortino ratio tells the downside risk-adjusted-returns of the mutual fund.
Information ratio is 0.74 as on September 2024. It tells the consistency of the fund in generating superior risk-adjusted performance
Tanmaya Desai, Mohit Jain are the fund managers of SBI Healthcare Opportunities Fund Direct Growth
The Exit load of SBI Healthcare Opportunities Fund Direct Growth is 0.5%